CTSD and acute myeloid leukemia: Furthermore, higher CTSD expression was found in AML patients whose malignant cells have monocytic phenotypes (AML-M4 and -M5 subtypes) than those with the M0, M1, M2, and M3 subtypes of AML (Fig. 1D).